2025 annual financial data

Verrica Pharmaceuticals 2025 Net margin

Direct answer

Net margin was -50.27%.

Operating income was -11,939,000 USD and net income was -17,886,000 USD.
Operating cash flow was -17,627,000 USD.

Get free Verrica Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
35,577,000 USD
Operating income
-11,939,000 USD
Net income
-17,886,000 USD
Operating cash flow
-17,627,000 USD